Skip to main content
Tech.euFundingExplorerBeta

Glenview Capital

Investor profile

Venture capital

Glenview Capital has backed 2 European tech companies across 2 funding rounds between 2021 and 2024, joining rounds totalling €262M. Most active in Healthtech. Data as of 4 Nov 2026.

Deals
2
distinct rounds
Companies
2
backed
Active span
2021–2024
4 yrs
Total round €
€262M
sum of rounds joined

Deals by year

distinct rounds / year
Glenview Capital — deals by year — interactive chart.
Data table
Glenview Capital — deals by year
20211
20241

Top sectors

by deals
Glenview Capital — top sectors — interactive chart.
Data table
Glenview Capital — top sectors
Healthtech2

Stages

by deals
Glenview Capital — stages — interactive chart.
Data table
Glenview Capital — stages
Series D+2

Countries

by deals
Glenview Capital — countries — interactive chart.
Data table
Glenview Capital — countries
UK2

Co-investment network

shared rounds
Co-investment network — interactive chart.
Glenview Capital — 2 dealsGlenview CapitalNovo Holdings — 2 shared deals · click to openNovo HoldingsAncora Finance Group — 1 shared deals · click to openAncora Finance Groupb2venture — 1 shared deals · click to openb2ventureBlackRock — 1 shared deals · click to openBlackRockEldridge — 1 shared deals · click to openEldridgeMillennium Venture Capital — 1 shared deals · click to openMillennium Venture CapitalMonashee Investment Management LLC — 1 shared deals · click to openMonashee Investment Management LLCOrlando Health — 1 shared deals · click to openOrlando HealthPuhua Capital — 1 shared deals · click to openPuhua CapitalSands Capital Ventures — 1 shared deals · click to openSands Capital VenturesSegulah Medical — 1 shared deals · click to openSegulah Medical

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
QuantaUK1€205M
Quanta Dialysis TechnologiesUK1€57M

Biggest deals

top 10 by amount
CompanyStageAmountDate
QuantaSeries D+€205M2021-06
Quanta Dialysis TechnologiesSeries D+€57M2024-11
← Back to investors